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Volume 51, Number 11S Abstracts 21S4 years, actuarial survival rate was 77%, primary patency was
80% but secondary patency was 95%. Primary patency was
adversely affected by an axillofemoral revascularization (HR
3.5, p 0.01), and ESRD (HR 10.6, p 0.03). Diabetes
(HR 12.7, p 0.04) and tissue loss (HR 13.7, p 0.01)
were predictors of limb loss.
Conclusions: Surgery for AIOD is currently per-
formed for failed endovascular therapy or advanced aor-
toiliac occlusion. Despite more challenging anatomy
outcomes remain durable and comparable to historical
series. Maintenance of proficiency in this surgical recon-
struction is essential.
Patient Characteristics
Patient
characteristics
All patients
(n  205)
Aortofemoral
Bypass
(n  142)
Axillofemoral
Bypass
(n  63) p-value
DM 25.4 (50) 26.4 (37) 22.8 (13) 0.60
Renal Insufficiency 8.4 (17) 3.6 (5) 19.3 (12) 0.001
ESRD 2.5 (5) 0 (0) 8.1 (5) 0.002
Hypertension 62.1 (126) 59.3 (83) 68.2 (43) 0.22
High cholesterol 58.9 (119) 53.3 (83) 58.1 (36) 0.87
CAD 38.2 (78) 37.6 (53) 39.7 (25) 0.78
CHF 4.4 (9) 2.1 (3) 9.5 (6) 0.03
Prior MI 18.1 (37) 13.5 (19) 28.6 (18) 0.01
COPD 15.2 (31) 13.5 (19) 19.0 (12) 0.31
Smoking status 0.02
Never 16.2 (33) 13.4 (19) 22.6 (14)
Former 37.2 (76) 33.8 (48) 45.2 (28)
Current 46.6 (95 52.8 (75) 32.3 (20)
Statin 57.1 (116) 60.3 (85) 50.0 (31) 0.17
ASA use 58.1 (118) 53.9 (76) 67.7 (42) 0.066
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Objectives: Determining operative risk in patients un-
dergoing aortic surgery is a difficult process, as multiple
variables converge to impact overall mortality. Patient
frailty is certainly a contributing factor, but is difficult to
measure, with surgeons often relying on subjective or intu-
itive influences. We sought to utilize sarcopenia as an
objective measure of frailty, and determine its utility as a
predictor of survival following AAA repair.
Methods: 479 patients underwent elective open AAA
repair between 2000 and 2008. 262 patients (54.7%) had
preoperative CT scans available for analysis. Cross-sectional
areas of the psoas muscles at the level of the L4 vertebra
were measured. Postoperative survival and psoas area were
analyzed using a univariable model.Results: Mortality rates ranged from 1.9% (n  5) at
30 days to 6.1% at 180 days (n 16). At 60, 90, and 180
days postoperatively, the groups of patients who died
had significantly smaller mean psoas areas. When strati-
fied into tertiles of psoas area, the group of patients with
the smallest psoas area (vs the largest psoas area group)
had a higher mortality rate at 60 days (9.1% vs 1.1%, p 
0.03), 90 days (10.2% vs 1.1%, p  0.02), and 180 days
(12.5% vs 1.1%, p  0.005). Figure 1 demonstrates the
stepwise relationship between psoas area and mortality.
Conclusions: Central sarcopenia, an objective measure
of frailty, correlates strongly with mortality following elective
AAA repair. A better understanding of the role of frailty and
sarcopenia may aid in risk stratification and impact timing of
surgical repair, especially in more complex aortic operations.
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Objectives: The rate of failure of access procedures is
high and many of these are unanticipated. A more compre-
hensive arterial evauation can lead to changes in the plan-
ning for dialysis access. A simple schema for arterial study by
ultrasound in presented.
Methods: 74 consecutive ultrasound exams were per-
formed for 38 primary elective (51%) and 36 primary (49%)
(with catheters) access cases with ages 28 to 87 including 40
females and 34 males. The Brachial arteries and bifurcations
were completely interrogated for pulsatility, atheroma and
anomalies. The Radial arteries were interrogated for ather-
oma, circumfrential stenosis, shadowing, diameter and wave-
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completeness of the digital arch, and Doppler Allen tests.
Results: BRACHIAL ARTERY ABNORMALITIES;
SEVERE ATHEROMA 10 14%; SMALL ARTERY 3 4%
ANOMALIES 5 7%; high bifurcation 4 5%; low bifurcation
1 1%; BIFURCATION ATHEROMA 2 3%; PROXIMAL
ULNAR 1 1%; PROXIMAL RADIAL 4 5%; RADIAL
ARTERY ABNORMALITIES; ATHEROMA AND
SHADOWING 9 12% DISCONTINUITY 1 1%; SMALL
ARTERY 5 7%; EXCISED 1 1%; INCOMPLETE DIGI-
TAL ARCH 12 16%. Information to adjust the location of
the anastamosis was obtained in 15%. In 27% concern for
possible steal was noted. For Brachial artery anomalies (7%)
the contralateral arm was used.
Conclusions: A more comprehensive arterial evalua-
tion prior to Dialysis Access Surgery can uncover arterial
problems that could lead to failure of the surgery. Most of
these problems can be adressed by a change in location of
the access or using the other arm.
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Objectives: We have previously reported that Protein
kinase C-delta (PKC), a mediator of apoptosis, is signifi-
cantly upregulated in human abdominal aortic aneurysm
(AAA) vessel walls. In the present study, we tested the effect
of PKC gene deficiency on aneurysm development in
mice.
Methods: AAAwas induced by Angiotensin II (AngII)
in ApoE knock-out (KO) mice or by calcium chloride
(CaCl2) in C57BL/6 mice, PKC KO mice and their wild
type (WT) littermates.
Results: Compared to the normal aortic wall, PKC
expression was markedly elevated within 3 to 7 days in both
AngII andCaCl2 inducedAAAs accompanied by apoptosis of
smooth muscle cells (SMCs) and increased expression of
Monocyte Chemoattractant Protein-1 (MCP-1). CaCl2 in-
duced AAA formation was significantly suppressed in PKC
KOmice compared to theirWT littermate (1.13 v.s. 1.79 fold
increase in diameter, p  0.01, n  5, Figure 1). Apoptosis,
MCP-1 expression and macrophage infiltration was attenu-
ated in the aortic wall of PKC KO mice. PKC KO SMCs,
isolated from the aorta, were resistant to apoptosis and
showed profound impairment in TNF- induced MCP-1
production compared toWT SMCs (31.0 2.7 v.s. 646.1
177.1 pg/mL, p 0.01, n 3).
Conclusions: These findings suggest that PKC con-
tributes to AAA formation through the stimulation ofapoptosis and inflammation and may be a potential target
for future therapies.
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Objectives: To assess trends in open and endovascular
repair (EVAR) of intact abdominal aortic aneurysm (iAAA)
and ruptured (rAAA) in the Medicare population.
Methods: We identified all Medicare beneficiaries with
a diagnosis of AAA who either underwent repair, or had a
primary diagnosis of rupture (1995-2008). We evaluated
trends in type of repair (open vs EVAR), presentation
(iAAA vs rAAA), and 30-day mortality. Time trends were
analyzed using regression models & associated statistical
tests.
